1 / 8

Sepsis Diagnostics Market Leading Growth Drivers, Emerging Audience

The sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028.<br>

Robert105
Télécharger la présentation

Sepsis Diagnostics Market Leading Growth Drivers, Emerging Audience

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sepsis DiagnosticsMarket Analysis, Regional Outlook, Business Landscape 2027 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

  3. Email:sales@theinsightpartners.com Sepsis Diagnostics Market Overview • The Sepsis Diagnostics Marketis projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. • The sepsis diagnostics market growth is attributed to the high incidence of sepsis due to increasing nosocomial infections and rise in demand for rapid diagnostic tests leading to increasing product launches. However, the lack of skilled professionals hampers the market growth. Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients.

  4. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Instrument, Reagent And Assay, Blood Culture Media, And Software.) • By Technology (Molecular Diagnostics, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, And Microbiology) • End-User (Hospitals, Pathology And Reference Laboratories, And Others.) Download Sample

  5. Email:sales@theinsightpartners.com Sepsis Diagnostics Market Value CAGR of 9.2% (2021 - 2028) Download Sample

  6. Email:sales@theinsightpartners.com Company Profiles • Abbott • F. HOFFMANN-LA ROCHE LTD. • Immunexpress Inc. • BD • Danaher • Luminex Corporation • Thermo Fisher Scientific Inc. • bioMerieux SA. • T2 Biosystems, Inc. • Axis-Shield Diagnostics Ltd. Download Sample

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related